Biotherapy Development Association
20 Jul 2010
Biotherapy Development Association
An immunotherapy approach to pancreatic cancer
The PRIMA study
ALK mutation related non-small cell lung cancer
Targeted therapy in sarcoma treatment
Prognostic and predictive markers in breast cancer
Next generation proteasome inhibitors
Treating bone disease in multiple myeloma
Views on the joint ASCO-ASH education session
Views on the joint ASCO-ASH education session
The efficacy of denosumab and zoledronic acid as treatment for prostate cancer
Circulating tumour cells in breast cancer